+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Australia Medical Device Contract Manufacturing Market - Distribution by Application Area, Target Therapeutic Area, and Device Class: Industry Trends and Global Forecasts, till 2035- Product Image
Australia Medical Device Contract Manufacturing Market - Distribution by Application Area, Target Therapeutic Area, and Device Class: Industry Trends and Global Forecasts, till 2035- Product Image
New

Australia Medical Device Contract Manufacturing Market - Distribution by Application Area, Target Therapeutic Area, and Device Class: Industry Trends and Global Forecasts, till 2035

  • PDF Icon

    Report

  • 120 Pages
  • March 2026
  • Region: Australia, Global
  • Roots Analysis
  • ID: 6230118
Description Jump to:
The Australia medical device contract manufacturing market is estimated to grow from USD 6.0 billion in the current year to USD 18.23 billion by 2035 at a CAGR of 13% during the forecast period, till 2035.


Australia medical device contract manufacturing market: Growth and Trends

The contract manufacturing medical devices (MDCMO) market is experiencing significant growth fueled by the increasing prevalence of chronic diseases worldwide. It is important to highlight that patients with chronic conditions require ongoing medical supervision to effectively manage their disease progression. However, many individuals face challenges while accessing healthcare facilities, including distance and the additional costs associated with diagnostic testing. To mitigate these challenges, medical devices and smart wearables are emerging as effective solutions, enabling remote monitoring of health metrics and delivery of appropriate interventions.

According to the World Health Organization, there are approximately two million distinct types of medical devices worldwide, classified into more than 7,000 general categories. These devices were developed to enhance patient adherence and allow for treatment without geographical constraints.. Medical device contract manufacturing functions as an outsourcing approach that utilizes specialized knowledge to produce particular components or complete devices for another organization. Notably, outsourcing medical device production provides significant advantages to firms in this sector by allowing them to bypass the need to set up manufacturing facilities, lower overall production expenses, and concentrate on their primary operations. Medical device contract manufacturers offer a range of outsourcing services, including device development, installation, manufacturing, quality assurance, regulatory guidance, and supply chain management.

Key elements driving the expansion of the medical device contract manufacturing market include the increasing elderly population and the demand for advanced technology-based devices for rapid monitoring. Additionally, the growing emphasis on patient-oriented medical devices for disease diagnosis and clinical research has amplified the need for cutting-edge remote monitoring equipment that assists in tracking health metrics from a distance.

The Australia medical device contract manufacturing market shows robust growth activity in the short-term, driven by outsourcing trends and demand for advanced devices such as next-generation implants, diagnostics, and wearable health monitors. This expansion is also fueled by an aging population, prompting original equipment manufacturers (OEMs) to partner with local CDMOs for cost efficiencies, thus reducing in-house capital needs faster time-to-market through specialized capabilities in Class III device assembly and regulatory compliance.

Growth Drivers: Strategic Enablers of Market Expansion

The market for medical device contract manufacturing in Australia is experiencing growth due to a rising demand for advanced medical devices, driven by the heightened need for diagnostics, implants, and equipment for home use. Companies outsource extensively to specialized contract manufacturers, slashing capital expenditures on facilities while accelerating development timelines through access to expertise of contract manufacturers. Further, technological advancements, including automation, 3D printing, and AI-driven quality control, enable faster prototyping and scalability, attracting numerous biotech firms and MedTech players alongside giants like Pfizer and Novartis that leverage local CDMOs for compliant production.

Market Challenges: Critical Barriers Impeding Progress

Despite encouraging development, Australia sector faces fundamental challenges that slows its swift progress in the medical device contract manufacturing market. Compliance with the Therapeutic Goods Administration (TGA)'s rigorous standards for Class I-III devices create significant barriers, demanding extensive documentation, audits, and validation that delay market entry and raise costs. Supply chain disruptions exacerbated by global events lead to raw material shortages for critical components like biocompatible polymers and electronics, forcing production halts and inventory stacking. In addition, heightened competition from low-cost Asian manufacturers pressures pricing, while skilled labor shortages in specialized areas like cleanroom operations and regulatory affairs further strain capacity amid rising demand.

Therapeutic Medical Devices Dominating Market Segment

In terms of application areas, the medical device contract manufacturing market is segmented into therapeutic medical devices, diagnostic medical devices, drug delivery medical devices and others. Our projections indicate that therapeutic medical devices hold the largest market share, anticipated to account for 31% of total revenue in the long term. This is due to the rising demand for therapeutic devices like insulin pumps, respiratory equipment, and infusion pumps used for managing chronic illnesses. However, the drug delivery devices have shown the highest growth potential and are estimated to grow at a higher CAGR during the forecast period.

Orthopedic Disorders: Leading Market Segment

In terms of therapeutic application area, the medical device contract manufacturing market is bifurcated into cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others. Fueled by the increasing need for orthopedic devices and advanced materials for joint replacements, along with other joint-related issues in the elderly population, orthopedic disorders are projected to hold the largest share (20.9%) by 2035.

However, over the long term, metabolic disorders have demonstrated significant growth potential and are expected to grow at a higher CAGR throughout the forecast period. This can be linked to the swift rise in metabolic conditions like obesity, insulin resistance, Type 1 diabetes, and hypertension. Individuals with metabolic disorders need constant monitoring to manage their health conditions, which is expected to raise the need for medical devices

Australia medical device contract manufacturing market: Key Segments

Application Areas

  • Therapeutic Medical Devices
  • Diagnostic Medical Devices
  • Drug Delivery Medical Devices
  • Other Devices
Device Class
  • Class I
  • Class II
  • Class III

Target Therapeutic Area

  • Cardiovascular Disorders
  • CNS Disorders
  • Metabolic Disorders
  • Oncological Disorders
  • Ophthalmological Disorders
  • Orthopedic Disorders
  • Pain Disorders
  • Respiratory Disorders
  • Others

Example Players in Australia Medical Device Contract Manufacturing Market

  • Cochlear
  • CSL
  • Fisher & Paykel Healthcare
  • Freudenberg Medical
  • Johnson & Johnson
  • Medtronic
  • Nanosonics
  • Osmosis Medical
  • ResMed

Key Questions Answered in this Report

  • How many medical device contract manufacturers are currently engaged in this market?
  • Which are the leading companies in this market?
  • What are the key trends observed in the Australia medical device contract manufacturing market?
  • What factors are likely to influence the evolution of this market?
  • What are the primary challenges faced by medical device contract manufacturing market in Australia?
  • What is the current and future Australia medical device contract manufacturing market size?
  • What is the CAGR of Australia medical device contract manufacturing market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
  • The report can aid businesses in identifying future opportunities in any sector. It also helps in understanding if those opportunities are worth pursuing.
  • The report helps in identifying customer demand by understanding the needs, preferences, and behavior of the target audience in order to tailor products or services effectively.
  • The report equips new entrants with requisite information regarding a particular market to help them build successful business strategies.
  • The report allows for more effective communication with the audience and in building strong business relations.

Complementary Benefits

  • Complimentary Excel Data Packs Covering All Analytical Modules
  • Up to 15% Complimentary Content Customization
  • In-Depth Report Walkthrough with the Research Team
  • Complimentary Report Update if the Report is 6+ Months Old

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Value and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross-Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Medical Devices: An Overview
6.2.1. History of Medical Devices
6.2.2. Classification of Medical Devices
6.3. Medical Device Manufacturing
6.3.1. Challenges Associated with Medical Device Manufacturing
6.3.2. Role of CMOs in Medical Device Manufacturing
6.3.3. Role of Automation in Medical Device Manufacturing Process
6.4. Historical Timeline for Medical Device CMOs
6.5. Services Offered by Medical Device CMOs
6.6. Advantages Offered by Medical Device CMOs
6.7. Risks associated with Outsourcing to CMOs
6.8. Key Considerations
6.9. Concluding Remarks
7. REGULATORY LANDSCAPE FOR MEDICAL DEVICES
7.1. Chapter Overview
7.2. General Regulatory Guidelines for Medical Devices
7.3. Regulatory Landscape in Asia-Pacific
7.3.1. Regulatory Authority
7.3.2. Review / Approval Process
7.4. Conclusion
8. MARKET OVERVIEW
8.1. Chapter Overview
8.2. Medical Device CMOs Offering Services for Medical Devices
8.2.1. Analysis by Year of Establishment
8.2.2. Analysis by Size of Employee Base
8.2.3. Analysis by Location of Headquarters
8.2.4. Analysis by Location of Manufacturing Facility
8.2.5. Analysis by Regulatory Certifications / Accreditations
8.2.6. Analysis by Production Services Offered
8.2.7. Analysis by Post-production Services Offered
8.2.8. Analysis by Other Services Offered
8.2.9. Analysis by Device Class
8.2.10. Analysis by Type of Material(s) Handled
8.2.11. Analysis by Scale of Operation
8.2.12. Leading Players
9. COMPANY PROFILES: AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
9.1. Chapter Overview
9.2. Cochlear
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Financial Information
9.2.4. Recent Developments and Future Outlook
9.3. CSL
9.4. Fisher & Paykel Healthcare
9.5. Freudenberg Medical
9.6. Johnson & Johnson
9.7. Medtronic
9.8. Nanosonics
9.9. Osmosis Medical
9.10. ResMed
10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Analysis of Clinical Trials
10.2.1. Analysis by Trial Start Year
10.2.2. Analysis by Trial Status
10.2.3. Analysis by Phase of Development
10.2.4. Analysis by Target Indication
10.2.5. Analysis by Type of Sponsor
10.2.6. Analysis by Geography
10.2.7. Analysis by Trial Start Year and Geography
10.3. Analysis of Enrolled Patient Population
10.3.1. Analysis by Trial Status
10.3.2. Analysis by Phase of Development
10.3.3. Analysis by Geography
10.4. Analysis of Focus Therapeutic Areas
10.4.1. Analysis by Type of Sponsor
10.4.2. Analysis by Geography
11. MERGERS AND ACQUISITIONS
11.1. Chapter Overview
11.2. Merger and Acquisition Models
11.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
11.3.1. Analysis by Year of Mergers and Acquisitions
11.3.2. Analysis by Type of Acquisition
11.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
11.3.4. Analysis by Key Value Drivers
12. MARKET IMPACT ANALYSIS
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Australia Medical Device Contract Manufacturing Market, (Since 2023) and Forecasted Estimates (Till 2035)
13.4. Roots Analysis Perspective on Market Growth
13.5 Scenario Analysis
13.5.1. Conservative Scenario
13.5.2. Optimistic Scenario
13.6. Key Market Segmentations
14. MEDICAL DEVICE CONTRACT MANUFACTURING MARKET IN AUSTRALIA, BY APPLICATION AREA
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Device Contract Manufacturing Market in Australia: Distribution by Application Area
14.3.1. Medical Device Contract Manufacturing Market in Australia for Therapeutic Devices: Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
14.3.2. Medical Device Contract Manufacturing Market in Australia for Diagnostic Devices, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
14.3.3. Medical Device Contract Manufacturing Market in Australia for Drug Delivery Devices, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
14.3.4. Medical Device Contract Manufacturing Market in Australia for Other Devices, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
14.4. Data Triangulation and Validation
15. MEDICAL DEVICE CONTRACT MANUFACTURING MARKET IN AUSTRALIA, BY DEVICE CLASS
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Device Contract Manufacturing Market in Australia: Distribution by Device Class
15.3.1. Medical Device Contract Manufacturing Market in Australia for Class I Devices, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
15.3.2. Medical Device Contract Manufacturing Market in Australia for Class II Devices Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
15.3.3. Medical Device Contract Manufacturing Market in Australia for Class III Devices, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and
15.4. Data Triangulation and Validation
16. MEDICAL DEVICE CONTRACT MANUFACTURING MARKET IN AUSTRALIA, BY THERAPEUTIC AREA
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Device Contract Manufacturing Market in Australia: Distribution by Therapeutic Area
16.3.1. Medical Device Contract Manufacturing Market in Australia for Cardiovascular Disorders, Historical Trends (Since 2023) and Forecasted Estimates (Since 2023) and Forecasted Estimates (Till 2035)
16.3.2. Medical Device Contract Manufacturing Market in Australia for CNS Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.3. Medical Device Contract Manufacturing Market in Australia for Metabolic Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.4. Medical Device Contract Manufacturing Market in Australia for Oncological Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.5. Medical Device Contract Manufacturing Market in Australia for Orthopedic Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.6. Medical Device Contract Manufacturing Market in Australia for Ophthalmic Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.7. Medical Device Contract Manufacturing Market in Australia for Pain Disorders, (Since 2023) and Forecasted Estimates (Till 2035)
16.3.8. Medical Device Contract Manufacturing Market in Australia for Respiratory Disorders (Since 2023) and Forecasted Estimates (Till 2035)
16.3.9. Medical Device Contract Manufacturing Market in Australia for Other Therapeutic Areas, (Since 2023) and Forecasted Estimates (Till 2035)
16.4. Data Triangulation and Validation
17. CONCLUDING REMARKS18. APPENDIX I: TABULATED DATA19. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 4.1. Single-use Bioreactors: Distribution by Type of Bioreactor
Figure 4.2. Single-use Bioreactors: Distribution by Scale of Operation
Figure 4.3. Single-use Bioreactors: Distribution by Type of Cell Culture System
Figure 4.4. Single-use Bioreactors: Distribution by Type of Cell Culture
Figure 4.5. Single-use Bioreactors: Distribution by Type of Molecule Processed
Figure 4.6. Single-use Bioreactors: Distribution by Key Features
Figure 4.7. Single-use Bioreactors: Distribution by Application Area
Figure 4.8. Single-use Bioreactors: Distribution by End Users
Figure 4.9. Single-use Bioreactors: Distribution of Developers by Year of Establishment
Figure 4.10. Single-use Bioreactors: Distribution of Developers by Company Size
Figure 4.11. Single-use Bioreactors: Distribution of Developers by Leading Players
Figure 4.12. Single-use Bioreactors: Distribution of Developers by Location of Headquarters
Figure 5.1. Single-use Mixers: Distribution by Scale of Operation
Figure 5.2. Single-use Mixers: Distribution by Type of Mixing System
Figure 5.3. Single-use Mixers: Distribution by Type of Molecule Processed
Figure 5.4. Single-use Mixers: Distribution by Key Features
Figure 5.5. Single-use Mixers: Distribution by Application Area
Figure 5.6. Single-use Mixers: Distribution of Developers by Year of Establishment
Figure 5.7. Single-use Mixers: Distribution of Developers by Company Size
Figure 5.8. Single-use Mixers: Distribution of Developers by Geographical Region
Figure 5.9. Single-use Mixers: Distribution of Developers by Year of Establishment and Company Size
Figure 5.10. Single-use Mixers: Distribution of Developers by Leading Players
Figure 6.1. Single-use Sensors: Distribution by Type of Sensor
Figure 6.2. Single-use Sensors: Distribution by Type of Sensor Calibration
Figure 6.3. Single-use Sensors: Distribution by Sterilization Techniques
Figure 6.4. Single-use Sensors: Distribution by Application Area
Figure 6.5. Single-use Sensors: Distribution by Material of Construction
Figure 6.6. Single-use Sensors: Distribution of Developers by Year of Establishment
Figure 6.7. Single-use Sensors: Distribution of Developers by Company Size
Figure 6.8. Single-use Sensors: Distribution of Developers by Geographical Region
Figure 8.1. Product Competitiveness Analysis: Single-use Bioreactor developers based in North America
Figure 8.2. Product Competitiveness Analysis: Single-use Bioreactor developers based in Europe
Figure 8.3. Product Competitiveness Analysis: Single-use Bioreactor developers based in Asia-Pacific
Figure 8.4. Product Competitiveness Analysis: Single-use Mixer developers based in North America
Figure 8.5. Product Competitiveness Analysis: Single-use Mixer developers based in Europe
Figure 8.6. Product Competitiveness Analysis: Single-use Sensor developers based in North America
Figure 8.7. Product Competitiveness Analysis: Single-use Sensor developers based in Europe
Figure 9.1. Avantor: Annual Revenues, 2016- 9M 2021 (USD Billion)
Figure 9.2. Cytiva: Annual Revenues, 2016- 9M 2021 (USD Billion)
Figure 9.3. Merck KGaA: Annual Revenues, 2017- 9M 2021 (USD Billion)
Figure 9.4. Thermo Fisher Scientific: Annual Revenues, 2016- 9M 2021 (USD Billion)
Figure 10.1. Eppendorf: Annual Revenues, 2016- 2020 (EUR Billion)
Figure 10.2. Saint-Gobain: Annual Revenues, 2016- 9M 2021 (EUR Billion)
Figure 10.3. Sartorius: Annual Revenues, 2016- 9M 2021 (EUR Billion)
Figure 12.1. Patent Analysis: Cumulative Distribution by Publication Year
Figure 12.2. Patent Analysis: Distribution by Type of Patents
Figure 12.3. Patent Analysis: Geographical Distribution by Issuing Authority
Figure 12.4. Patent Analysis: Cumulative Year wise trend of Patents
Figure 12.5. Patent Analysis: Distribution by Type of Organization
Figure 12.6. Patent Analysis: Distribution by Patent Age
Figure 12.7. Patent Analysis: Distribution by Patent Valuation
Figure 12.8. Patent Analysis: Distribution by Most Popular CPC Symbol
Figure 12.9. Patent Analysis: Leading Industry Players
Figure 12.10. Patent Analysis: Leading Academic Players
Figure 12.11. Patent Analysis: Leading Patent Assignees
Figure 13.1. Brand Positioning Matrix of Single-use Bioreactors: Pall
Figure 13.2. Brand Positioning Matrix of Single-use Bioreactors: Eppendorf
Figure 13.3. Brand Positioning Matrix of Single-use Bioreactors: Solaris Biotech
Figure 13.4. Brand Positioning Matrix of Single-use Bioreactors: Sartorius Stedim Biotech
Figure 13.5. Brand Positioning Matrix of Single-use Bioreactors: Applikon Biotechnology
Figure 13.6. Brand Positioning Matrix of Single-use Bioreactors: CerCell
Figure 13.7. Brand Positioning Matrix of Single-use Bioreactors: Sythecon
Figure 13.8. Brand Positioning Matrix of Single-use Mixers: Thermo Fisher Scientific
Figure 13.9. Brand Positioning Matrix of Single-use Mixers: Merck Millipore
Figure 13.10. Brand Positioning Matrix of Single-use Mixers: Cytiva
Figure 13.11. Brand Positioning Matrix of Single-use Mixers: Pall
Figure 13.12. Brand Positioning Matrix of Single-use Sensors: Masterflex
Figure 13.13. Brand Positioning Matrix of Single-use Sensors: Levitronix
Figure 13.14. Brand Positioning Matrix of Single-use Sensors: Malema Engineering
Figure 13.15. Brand Positioning Matrix of Single-use Sensors: Parken Hannif
Figure 13.16. Brand Positioning Matrix of Single-use Sensors: Pendo TECH
Figure 14.1. Cost Saving Analysis (Equipment Cost)
Figure 14.2. Cost Saving Analysis (Manufacturing Cost)
Figure 15.1. Demand and Supply Analysis: Demand for Biologics, Till 2035
Figure 15.2. Demand and Supply Analysis: Demand and Supply, Till 2035
Figure 16.1. Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Scale of Operation
Figure 16.2. Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Type of Equipment
Figure 16.3. Single-use Upstream Bioprocessing Technology Market for Single-use Filters, Till 2035
Figure 16.4. Single-use Upstream Bioprocessing Technology Market for Single-use Media Bags, Till 2035
Figure 16.5. Single-use Upstream Bioprocessing Technology Market for Single-use Bioreactors, Till 2035
Figure 16.6. Single-use Upstream Bioprocessing Technology Market for Single-use Mixers, Till 2035
Figure 16.7. Single-use Upstream Bioprocessing Technology Market for Single-use Connectors, Till 2035
Figure 16.8. Single-use Upstream Bioprocessing Technology Market for Single-use Sampling Systems, Till 2035
Figure 16.9. Single-use Upstream Bioprocessing Technology Market for Single-use Membrane Adsorbents, Till 2035
Figure 16.10. Single-use Upstream Bioprocessing Technology Market for Other Single-use Technology, Till 2035
Figure 16.11. Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Geography
Figure 16.12. Single-use Upstream Bioprocessing Technology Market, Till 2035: Distribution by Geography
Figure 16.13. Single-use Upstream Bioprocessing Technology Market in North America, Till 2035
Figure 16.14. Single-use Upstream Bioprocessing Technology Market in North America, Till 2035: Distribution by Type of Equipment
Figure 16.15. Single-use Upstream Bioprocessing Technology Market in Europe, Till 2035
Figure 16.16. Single-use Upstream Bioprocessing Technology Market in Europe, Till 2035: Distribution by Type of Equipment
Figure 16.17. Single-use Upstream Bioprocessing Technology Market in Asia-Pacific, Till 2035
Figure 16.18. Single-use Upstream Bioprocessing Technology Market, Till 2035 in Asia-Pacific: Distribution by Type of Equipment
Figure 16.19. Single-use Upstream Bioprocessing Technology Market in Latin America, Till 2035
Figure 16.20. Single-use Upstream Bioprocessing Technology Market in Latin America, Till 2035: Distribution by Type of Equipment
Figure 16.21. Single-use Upstream Bioprocessing Technology Market in Middle East and North Africa, Till 2035
Figure 16.22. Single-use Upstream Bioprocessing Technology Market in Middle East and North Africa, Till 2035: Distribution by Type of Equipment
LIST OF TABLES
Table 4.1. Single-use Bioreactors: Information on Developers, Scale of Operation, Key Features, Type of Cell Culture System, Type of Cell Culture, Type of Molecule and Application Areas
Table 5.1. Single-use Mixers: Information on Developers, Scale of Operation, Type of Mixing System, Type of Molecule used, Key Features and Application Areas
Table 6.1. Single-use Sensors: Information on Developers, Product Specific Details, Type of Bioprocessing, Sterilization Techniques used and Application Areas
Table 7.1. Single-use Media Bags and Containers: Information on Developers, Purpose of Product, Type of Material / Tubing used, Key Features and Application Areas
Table 7.2. Single-use Filters: Information on Developers, Material of Construction, Key Features and Application Areas
Table 7.3. Single-use Connectors: Information on Developers, Material of Construction, Gender / Valve, Sterilizability, Key Features and Application Areas
Table 7.4. Single-use Sampling Systems: Information on Developers, Tubing Material, Sampling Unit, Sterilizability, Key Features and Application Areas
Table 9.1. Avantor: Product Portfolio (Single-use Bags and Containers)
Table 9.2. Avantor: Product Portfolio (Single-use Mixers)
Table 9.3. Cytiva: Product Portfolio (Single-use Bioreactors)
Table 9.4. Cytiva: Product Portfolio (Single-use Mixers)
Table 9.5. Merck KGaA: Product Portfolio (Single-use Bioreactors)
Table 9.6. Merck KGaA: Product Portfolio (Single-use Mixers)
Table 9.7. Merck KGaA: Product Portfolio (Single-use Filters)
Table 9.8. Pall: Product Portfolio (Single-use Bioreactors)
Table 9.9. Pall: Product Portfolio (Single-use Media Bags and Containers)
Table 9.10. Pall: Product Portfolio (Single-use Mixers)
Table 9.11. Thermo Fisher Scientific: Product Portfolio (Single-use Media Bags and Containers)
Table 9.12. Thermo Fisher Scientific: Product Portfolio (Single-use Mixers)
Table 10.1. Eppendorf: Product Portfolio (Single-use Bioreactors)
Table 10.2. Saint Gobain: Product Portfolio (Single-use Media Bags and Containers)
Table 10.3. Sartorius: Product Portfolio (Single-use Media Bags and Containers)
Table 11.1. Satake Multimix: Product Portfolio (Single-use Bioreactors)
Table 11.2. Reprocell: Product Portfolio (Single-use Bioreactors)
Table 11.3. Premas Biotech: Product Portfolio (Single-use Bioreactors)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cochlear
  • CSL
  • Fisher & Paykel Healthcare
  • Freudenberg Medical
  • Johnson & Johnson
  • Medtronic
  • Nanosonics
  • Osmosis Medical
  • ResMed

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies - Product Image

Medical Device CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Target Therapeutic Area, Scale of Operation, Device Class, Type of Clinical Service Offered, Type of Preclinical Service Offered and Key Geographies

  • Report
  • 560 Pages
  • Global
From
Medical Device Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Device Class, Target Therapeutic Area, and Key Geographical Regions - Product Image

Medical Device Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Device Class, Target Therapeutic Area, and Key Geographical Regions

  • Report
  • 323 Pages
  • Global
From
Sterile Tube Welder Market Report 2026 - Product Image

Sterile Tube Welder Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Ultrasonic Air Bubble Detectors Market - Forecast from 2026 to 2031 - Product Image

Ultrasonic Air Bubble Detectors Market - Forecast from 2026 to 2031

  • Report
  • 144 Pages
  • Global
From
Japan Digital Therapeutics Market, till 2035: Industry Trends and Forecasts - Distribution by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business Model and Target Therapeutic Area - Product Image

Japan Digital Therapeutics Market, till 2035: Industry Trends and Forecasts - Distribution by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business Model and Target Therapeutic Area

  • Report
  • Japan
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.